User profiles for Alberto H. Vargas
Hebert Alberto VargasNew York University Grossman School of Medicine Verified email at nyulangone.org Cited by 13371 |
Multimodality imaging of prostate cancer
Prostate cancer is a very heterogeneous disease, and contemporary management is
focused on identification and treatment of the prognostically adverse high-risk tumors while …
focused on identification and treatment of the prognostically adverse high-risk tumors while …
[HTML][HTML] METastasis reporting and data system for prostate cancer: practical guidelines for acquisition, interpretation, and reporting of whole-body magnetic resonance …
…, E Sala, HP Schlemmer, G Petralia, HA Vargas… - European urology, 2017 - Elsevier
Context Comparative reviews of whole-body magnetic resonance imaging (WB-MRI) and
positron emission tomography/computed tomography (CT; with different radiotracers) have …
positron emission tomography/computed tomography (CT; with different radiotracers) have …
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel
Vaccination-associated adenopathy is a frequent imaging finding after administration of
COVID-19 vaccines that may lead to a diagnostic conundrum in patients with manifest or …
COVID-19 vaccines that may lead to a diagnostic conundrum in patients with manifest or …
Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness
Purpose To assess the incremental value of diffusion-weighted (DW) magnetic resonance (MR)
imaging over T2-weighted MR imaging at 3 T for prostate cancer detection and to …
imaging over T2-weighted MR imaging at 3 T for prostate cancer detection and to …
Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade
Importance The anti–programmed cell death protein 1 (PD-1) antibody pembrolizumab is
approved by the US Food and Drug Administration for the treatment of microsatellite instability–…
approved by the US Food and Drug Administration for the treatment of microsatellite instability–…
Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making
Purpose A long natural history and a predominant osseous pattern of metastatic spread are
impediments to the adoption of precision medicine in patients with prostate cancer. To …
impediments to the adoption of precision medicine in patients with prostate cancer. To …
Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System)
Context Management of bladder cancer (BC) is primarily driven by stage, grade, and biological
potential. Knowledge of each is derived using clinical, histopathological, and radiological …
potential. Knowledge of each is derived using clinical, histopathological, and radiological …
[HTML][HTML] Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient
…, S Pourpe, H Veeraraghavan, Y Li, HA Vargas… - Cell, 2017 - cell.com
We present an exceptional case of a patient with high-grade serous ovarian cancer, treated
with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions …
with multiple chemotherapy regimens, who exhibited regression of some metastatic lesions …
Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different …
Objectives To investigate Haralick texture analysis of prostate MRI for cancer detection and
differentiating Gleason scores (GS). Methods One hundred and forty-seven patients …
differentiating Gleason scores (GS). Methods One hundred and forty-seven patients …
Automatic classification of prostate cancer Gleason scores from multiparametric magnetic resonance images
Noninvasive, radiological image-based detection and stratification of Gleason patterns can
impact clinical outcomes, treatment selection, and the determination of disease status at …
impact clinical outcomes, treatment selection, and the determination of disease status at …